Adyen Expands Healthcare Footprint with LillyDirect Payment Deal
Event summary
- Adyen will provide payment technology services for LillyDirect, enabling direct-to-consumer access to FDA-approved medicines.
- LillyDirect will offer flexible payment options including credit/debit cards, digital wallets (Apple Pay, Google Pay), and HSA/FSA cards.
- Adyen's Intelligent Payment Routing will optimize transaction efficiency using AI-powered network selection.
- The deal underscores Adyen's growth in healthcare and expansion with new merchants.
The big picture
This partnership aligns with the broader shift toward direct-to-consumer models in U.S. healthcare, where seamless payment solutions are critical for patient adoption. Adyen's involvement highlights its strategic pivot into specialized verticals beyond traditional e-commerce, leveraging its scalable platform to support evolving consumer needs.
What we're watching
- Healthcare Digitalization
- How Adyen's payment solutions will influence patient experience in direct-to-consumer healthcare models.
- Market Expansion
- Whether Adyen can sustain growth by securing more high-profile healthcare clients.
- Technological Integration
- The pace at which AI-powered payment routing becomes standard in the fintech sector.
Related topics